Proficient Auto Logistics Reports Preliminary Fourth Quarter 2024 Financial Results — Neutral
PAL Business Wire — February 11, 2025JACKSONVILLE, Fla.--(BUSINESS WIRE)--Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company” or “Proficient”) today reported its preliminary financial results for the three months ended December 31, 2024, and comparative summary financial information for the Founding Companies (as defined below) on a combined basis for the three months ended December 31, 2023. Fourth Quarter Summary (fourth quarter 2023 information on a combined basis) Total Operating Revenue of $95.1 million, increased 4%.
Gilead Sciences (GILD 0.69%), a major player in the biotechnology sector, reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 11, that topped analysts' consensus estimates. Adjusted earnings per share of $1.90 came in well ahead of the estimated $1.74.
Gold Price Forecast: Record Highs for Gold, but Weak Close Looms — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL FXEmpire — February 11, 2025Gold surged to $2,943, hitting record highs before facing resistance. A weak closing price increases the chances that a bearish reversal may follow, with $2,882 as key near-term support.
Quipt Home Medical Corp. (QIPT) Q1 2025 Earnings Call Transcript — Neutral
QIPT Seeking Alpha — February 11, 2025Quipt Home Medical Corp. (NASDAQ:QIPT ) Q1 2025 Earnings Conference Call February 11, 2025 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Doug Cooper - Beacon Securities Julian Hung - Stifel Bill Sutherland - The Benchmark Company Operator Thank you for standing by. This is the conference operator.
Zurn Elkay Water Solutions Announces Launch of Public Offering of Common Stock by Selling Stockholder — Neutral
ZWS Business Wire — February 11, 2025MILWAUKEE--(BUSINESS WIRE)--Zurn Elkay Water Solutions Announces Launch of Public Offering of Common Stock by Selling Stockholder.
Teledyne to Participate at the TD Cowen Aerospace & Defense Conference — Neutral
TDY Business Wire — February 11, 2025THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will present at the TD Cowen 46th Annual Aerospace & Defense Conference at the Ritz-Carlton – Pentagon City in Arlington, Va. on Thursday, February 13, at 9:15 a.m. Eastern Time. A live webcast of Teledyne's presentation may be accessed via the company's website at www.teledyne.com/investors/events-an.
Everus Reports Strong Fourth Quarter and Full Year 2024 Results, Initiates Guidance for 2025 — Neutral
ECG Business Wire — February 11, 2025BISMARCK, N.D.--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) today reported financial results for the fourth quarter and full year 2024.
USA Compression Partners Announces Filing of 2024 Annual Report on Form 10-K — Neutral
USAC Business Wire — February 11, 2025DALLAS--(BUSINESS WIRE)--USA Compression Partners, LP (NYSE: USAC) (“USA Compression”) today announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (“SEC”). USA Compression's Annual Report on Form 10-K is available through its website at www.usacompression.com in the Investor Relations section under SEC Filings, as well as on the SEC's website at sec.gov. Interested investors may obtain a hard copy of.
Ford CEO says tariffs could 'blow a hole' in US auto industry — Negative
F Fox Business — February 11, 2025Ford CEO Jim Farley said at an analyst conference that while President Trump wants to help automakers, his Canada and Mexico tariffs could "blow a hole" in the U.S. auto industry.
Arcus Biosciences Announces New Employment Inducement Grants — Neutral
RCUS Business Wire — February 11, 2025HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that, in connection with the appointment of the Company's new Chief Medical Officer, Richard Markus, M.D., Ph.D., the Compensation Committee of the Company's Board of Directors granted Dr. Markus an option to purchase 305,328 shares of the Company's common stock.
Loews: At $87 It's Undervalued Given Management's Persistent History Of Success — Positive
L Seeking Alpha — February 11, 2025Loews: At $87 It's Undervalued Given Management's Persistent History Of Success
Mexican telecoms giant America Movil's profit slides on FX losses — Negative
AMX Reuters — February 11, 2025Mexican telecommunications giant America Movil on Tuesday reported a 48% fall in its fourth-quarter net profit, well below analysts' expectations, with the company citing foreign-exchange losses even as its revenues rose.
NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tidal Financial Group and Plato's Philosophy LLC announce the closure and liquidation of the Meet Kevin Pricing Power ETF (NYSE Arca: PP), effective February 28, 2025. This decision follows a thorough evaluation and was determined to be in the best interests of the fund and its shareholders.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages FTAI Aviation Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTAI — Neutral
FTAI GlobeNewsWire — February 11, 2025NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FTAI Aviation Ltd. (NASDAQ: FTAI) between July 23, 2024, and January 15, 2025, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of dia.
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results — Neutral
SUPN GlobeNewsWire — February 11, 2025ROCKVILLE, Md., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the fourth quarter and full year of 2024 after the market closes on Tuesday, February 25, 2025.
Chemours Appoints Leslie M. Turner to its Board of Directors — Neutral
CC Business Wire — February 11, 2025WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Leslie M. Turner to its Board of Directors.
CrowdStrike Announces Date of Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call — Neutral
CRWD Business Wire — February 11, 2025AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike Holdings, Inc. (Nasdaq: CRWD), today announced that it will release financial results for its fourth quarter and fiscal year 2025 ended January 31, 2025 after the U.S. market close on Tuesday, March 4, 2025. CrowdStrike will host a conference call that day at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss the results. To register for the live event please visit https://crowdstrike-q4-and-fy25-financial-results-conference-call.open-exchange.
Chimera Declares First Quarter 2025 Preferred Stock Dividends — Neutral
CIM Business Wire — February 11, 2025NEW YORK--(BUSINESS WIRE)--The Board of Directors of Chimera announced the declaration of its first quarter cash dividend of $0.50 per share of 8.00% Series A Cumulative Redeemable Preferred Stock. The dividend is payable March 31, 2025 to preferred shareholders of record on March 3, 2025. The ex-dividend date is March 3, 2025. The Board of Directors of Chimera also announced the declaration of its first quarter cash dividend of $0.6488 per share of 8.00% Series B Fixed-to-Floating Rate Cumulat.
Granite's $78 Million Road Congestion Relief Project in Anaheim, California — Neutral
GVA Business Wire — February 11, 2025WATSONVILLE, Calif.--(BUSINESS WIRE)--Granite (NYSE:GVA) has been awarded a $78 million infrastructure project by the California Department of Transportation (Caltrans) in Orange County, California. Project funding is to come from state and federal sources and will be included in Granite's first-quarter CAP. The project is centered around the demolition and reconstruction of a 320-foot-long concrete bridge. This new bridge is designed to improve mobility throughout the State Route 55 and State.